Home βΊ Calculator βΊ HYPMY Dividend Calculator 2026
HYPMY Dividend DRIP Calculator 2026
6.29% YieldHealthcareHypera S.A. Β· OTC
Price: $4.10 Β· Annual div: $0.26/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When HYPMY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your HYPMY snowball π
$10,000 in HYPMY β $5.82M in 10 years Β· $23.66/month
About Hypera S.A. (HYPMY) β Dividend Analysis 2026
Hypera S.A. is a prominent pharmaceutical enterprise primarily operating within Brazil. The company maintains a diverse product portfolio that includes a vast array of prescription medications, marketed under numerous brand names such as Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex Β A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid. Beyond prescription drugs, Hypera S.A. also provides dermo-cosmetic solutions, notably through its Mantecorp Skincare line. Its consumer health segment features well-known brands including Apracur, Benegrip, Coristina d, Engov, Epocler, and Estomazil, among others. Furthermore, the company offers nutritional and vitamin supplements, with labels such as Tamarine, Vitasay, BiotΓ΄nico Fontoura, and Zero-Cal. Hypera S.A. is also a producer and distributor of a range of similar and generic medicines, including its Neo QuΓmica brand, as well as products identified by active ingredients like Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel. Initially known as Hypermarcas S.A., the company officially rebranded to Hypera S.A. in February 2018. Its corporate headquarters are located in SΓ£o Paulo, Brazil.
Compare HYPMY with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HYPMY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open HYPMY position with:
π HYPMY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HYPMY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 6.29% | 3.49% | $629 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 5.35% | 2.55% | $535 / yr |
| πΊπΈ US Taxable (20%) | 20% | 5.03% | 2.23% | $503 / yr |
| π¬π§ UK ISA | 0% | 6.29% | 3.49% | $629 / yr |
| π¬π§ UK Taxable | 8.75% | 5.74% | 2.94% | $574 / yr |
| π¨π¦ TFSA | 0% | 6.29% | 3.49% | $629 / yr |
| π¨π¦ CA Taxable | 25% | 4.72% | 1.92% | $472 / yr |
| π¦πΊ Super (pension) | 15% | 5.35% | 2.55% | $535 / yr |
| π¦πΊ AU Taxable | 30% | 4.40% | 1.60% | $440 / yr |
| π©πͺ DE Taxable | 26.375% | 4.63% | 1.83% | $463 / yr |
| π«π· FR Taxable | 30% | 4.40% | 1.60% | $440 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― HYPMY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.26/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π HYPMY Dividend Payment Schedule
HYPMY pays quarterly β 4 times per year. Next ex-div: TBD.
π HYPMY vs Healthcare Benchmarks
How HYPMY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HYPMY sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ HYPMY Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HYPMY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Hypera S.A. (HYPMY) is currently trading at $4.10, 57% below its 52-week high. The current dividend yield is 6.29% based on an annual payout of $0.26 per share.
HYPMY (Hypera S.A.) β 6.29% Dividend Yield Analysis
Hypera S.A. (HYPMY) is a healthcare stock currently trading at $4.10 with a dividend yield of 6.29%. The company pays an annual dividend of $0.26 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, HYPMY has grown its dividend at a compound annual rate of 8.2%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only β not financial advice.